ENCY - I was wondering if anyone has been following it. It is due for FDA ruling by june 15th. GILD's version is due for ruling by June 18th. From all the reading I have done, it seems ENCY has more data, may be more effective but slightly more toxic. Both seem superior to Tracleer. I was wondering how other people were interpreting the data and what they were expecting the FDA to do. I think ENCY gets approved on the condition of post marketing studies. GILD will get approvable unless they pay off the FDA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.